Paperonium

← Back to the plain-language case

Abstract reverses the direction of the cerebellar IDH3A protein difference reported in Table 3B

Mol Psychiatry (2016) · doi:10.1038/mp.2015.217 · PMC5078854

Summary

The abstract states that protein expression of IDH3A in the cerebellum of patients with bipolar disorder (BD) "was higher than that of controls". The paper's own Table 3B gives the opposite: 0.804 ± 0.390 in BD against 1.227 ± 0.543 in controls (n = 15 per group). That is 0.423 units, or 34.5%, lower in BD, and the Results and Discussion both describe it as lower. Recomputing from the table's summary statistics reproduces its reported tests to rounding (ANOVA F(3, 56) = 5.73 against the printed 5.74, P = 0.0017; Dunnett P = 0.0172 for BD vs controls, printed 0.017), so the table and Results are internally consistent and only the abstract's direction word is wrong. The abstract is the most widely read and indexed part of the paper, and as printed it makes the protein result appear to contradict the lower IDH3A and IDH3B mRNA reported in the preceding sentence of the same abstract.

What the paper reports

Abstract:

Moreover, protein expression of IDH3A in the cerebellum from BD patients was higher than that of controls.

Abstract, preceding sentence (the mRNA result the protein finding is presented alongside):

Furthermore, gene expression of two subtypes (IDH3A and IDH3B) of isocitrate dehydrogenase (IDH) in the dorsolateral prefrontal cortex from BD patients was significantly lower than that of controls

Results, "Protein expression of IDH3A and IDH3B in the cerebellum and parietal cortex":

Results showed that protein levels of IDH3A in the cerebellum from BD (P=0.017), major depressive disorder (P=0.006) and schizophrenia (P=0.001) were significantly lower than in controls (Table 3B).

Table 3B, cerebellum row (columns: Controls n=15 | BD n=15 | MDD n=15 | Schizophrenia n=15 | One-way ANOVA):

IDH3A | 1.227±0.543 | 0.804±0.390* | 0.746±0.356** | 0.660±0.303** | F(3, 56)=5.74, P=0.002

Table 3B footer:

The data are the mean±s.d.*P<0.05, **P<0.01 (vs control, Dunnett's test).

Discussion, first paragraph:

Furthermore, protein levels of IDH3A in the cerebellar tissue from BD patients were lower than those in controls.

Discussion, second paragraph:

We did find reduced expression of IDH3A protein in the cerebellum in BD and other psychiatric disorders such as major depressive disorder and schizophrenia.

Taken all together, it is likely that decreased activity of IDH3A in the brain may play a crucial role in the pathogenesis of BD

The conclusions that draw on the finding. Abstract:

These findings suggest that abnormality in the metabolism of isocitrate by IDH3A in the mitochondria plays a key role in the pathogenesis of BD, supporting the mitochondrial dysfunction hypothesis of BD. Therefore, IDH3 in the citric acid cycle could potentially be a novel therapeutic target for BD.

Conclusions:

Our study provides evidence for abnormality in the metabolism of isocitrate by IDH3A in the pathogenesis of BD.

What the paper's own numbers show

Method. I took the group means and standard deviations printed in Table 3B (n = 15 per group, four groups) and Table 3A (dorsolateral prefrontal cortex, DLPFC, mRNA; controls n = 34, BD n = 35). For each Table 3B row I rebuilt the one-way ANOVA from the summary statistics (between-group and pooled within-group sums of squares, df 3 and 56). For the cerebellar IDH3A row I computed each patient group's difference from controls, the pooled-variance t statistic on 56 df, and the exact two-sided Dunnett P for three comparisons against a common control with equal n (correlation 0.5), by numerical integration rather than simulation. For all seven rows of Table 3A I ran Student and Welch two-sample t tests from the summary statistics, and found the range of P values each test can give when every printed mean and SD is allowed to be off by up to 0.0005 (their 3-decimal rounding). I also applied the Benjamini–Hochberg adjustment over the seven genes to the printed P values, to check the table's false discovery rate (FDR) column. Every number below is printed by recompute.py.txt.

Quantity Location Reported Recomputed from the paper's numbers
Direction of cerebellar IDH3A protein, BD vs controls Abstract "higher than that of controls" lower: BD − controls = 0.804 − 1.227 = −0.423 (−34.5%; ratio 0.655)
Direction of cerebellar IDH3A protein, BD vs controls Results; Discussion ¶1 and ¶2 "significantly lower"; "lower"; "reduced" lower (agrees with Table 3B)
Cerebellar IDH3A protein, controls vs BD Table 3B 1.227 ± 0.543 vs 0.804 ± 0.390* as printed; pooled t(56) = −2.84
One-way ANOVA, cerebellar IDH3A Table 3B F(3, 56) = 5.74, P = 0.002 F(3, 56) = 5.73, P = 0.0017 (rounding of the printed means and SDs allows F = 5.70 to 5.77)
Dunnett, BD vs controls, cerebellar IDH3A Results; Table 3B (*) P = 0.017 t = −2.840, P = 0.0172
Dunnett, MDD vs controls, cerebellar IDH3A Results; Table 3B (**) P = 0.006 t = −3.229, P = 0.0058
Dunnett, schizophrenia vs controls, cerebellar IDH3A Results; Table 3B (**) P = 0.001 t = −3.807, P = 0.0010
One-way ANOVA, cerebellar IDH3B Table 3B F(3, 56) = 2.30, P = 0.087 F = 2.30, P = 0.0869; BD − controls = −0.181
One-way ANOVA, parietal IDH3A Table 3B F(3, 56) = 2.58, P = 0.063 F = 2.58, P = 0.0628; BD − controls = −0.279
One-way ANOVA, parietal IDH3B Table 3B F(3, 56) = 0.63, P = 0.597 F = 0.63, P = 0.5959; BD − controls = −0.117
DLPFC IDH3A mRNA, controls vs BD Table 3A; Abstract ("lower") 1.466 ± 0.832 vs 1.017 ± 0.416, P = 0.007 BD − controls = −0.449 (−30.6%); Student P = 0.0058, Welch P = 0.0069
DLPFC IDH3B mRNA, controls vs BD Table 3A; Abstract ("lower") 1.198 ± 0.420 vs 0.957 ± 0.287, P = 0.007 BD − controls = −0.241 (−20.1%); Student P = 0.0069, Welch P = 0.0074
DLPFC mRNA, other Table 3A genes (unpaired t-test) Table 3A ACO1 0.178; ACO2 0.487; IDH1 0.755; IDH2 0.279; IDH3G 0.422 Student P: ACO1 0.175; ACO2 0.478; IDH1 0.758; IDH2 0.277; IDH3G 0.419. Each printed P lies inside the range that 3-decimal rounding of the means and SDs allows (for example ACO2 0.459 to 0.497)
FDR column, Table 3A Table 3A 0.414; 0.568; 0.755; 0.488; 0.026; 0.026; 0.568 (ACO1 … IDH3G) Benjamini–Hochberg of the printed P values: 0.415; 0.568; 0.755; 0.488; 0.025; 0.025; 0.568 (printed P ± 0.0005 gives 0.023 to 0.026 for IDH3A and IDH3B)
Cerebellar IDH3A protein, BD vs the other patient groups Table 3B — BD − MDD = +0.058; BD − schizophrenia = +0.144 (BD is higher only relative to these groups, not to controls)

All four one-way ANOVAs and the three Dunnett P values in Table 3B are reproduced to rounding from the printed summary statistics. In Table 3A, the printed t-test P values for IDH3A and IDH3B match the Welch test (0.0069 and 0.0074); the Student test gives 0.0058 for IDH3A, which does not round to the printed 0.007 even allowing for rounding of the inputs. For the other five genes the recomputed P values differ from the printed ones by up to 0.009 (ACO2: 0.478 against 0.487), but each printed value lies within the range that the 3-decimal rounding of the printed means and SDs allows, so these differences say nothing either way. The FDR column matches a Benjamini–Hochberg adjustment of the printed P values to rounding. None of this bears on the error: the only statement that disagrees with the numbers is the direction word in the abstract.

Figure

The abstract and the Results/Table 3B describe the same cerebellar IDH3A protein comparison in opposite directions

Figure 1. The two places in the paper that describe the same quantity: cerebellar IDH3A protein, BD vs controls, Stanley post-mortem samples, n = 15 per group. Left: the abstract sentence, with its direction word in orange (reported). Right: the Results sentence (black) and the Table 3B means (orange, reported), with the difference recomputed from those means in blue (BD − controls = −0.423, 34.5% lower). The connector marks the conflict. The Discussion, not shown in a panel, agrees with the Results. All text is quoted verbatim; all numbers come from Table 3B or recompute.py.txt.

BD/control ratios of means for IDH3A and IDH3B, recomputed from Tables 3A and 3B: all point estimates below 1

Figure 2. BD/control ratio of means for every IDH3A and IDH3B measurement in Tables 3A and 3B, on a log scale with 1 (no difference) as the reference line. Points and intervals (blue) are recomputed from the printed means and standard deviations; intervals are approximate 95% confidence intervals for the ratio by the delta method on the log scale and are shown only to convey precision, not as the paper's own analysis. The right-hand labels give the direction the abstract states for the three measurements it mentions; only the cerebellar IDH3A protein label (orange) conflicts with its point, which lies at 0.655 (95% CI 0.470 to 0.914). The figure shows that, read correctly, the protein result points the same way as the two mRNA results the abstract cites beside it.

Why it matters

Explanations considered

Status

As of 2026-10-23:

Suggested correction

In the abstract, replace

Moreover, protein expression of IDH3A in the cerebellum from BD patients was higher than that of controls.

with

Moreover, protein expression of IDH3A in the cerebellum from BD patients was lower than that of controls.

No change is needed to Table 3B, the Results, the Discussion or the Conclusions, which already report the direction correctly. Optionally, the corrected sentence could add the effect and test (0.804 ± 0.390 vs 1.227 ± 0.543; Dunnett P = 0.017) and note that the reduction was also seen in major depressive disorder and schizophrenia, as the Results state.